Figure 2.
Graft survival and peripheral immune responses. (A) Representative bioluminescent images of the transplanted mGRPs and (B) graft survival over time. The immune modulators didn`t impact the graft survival. (C) Peripheral cytokines measured over time by groups with expected reduction of pro-inflammatory cytokine levels by additional use of immune modulators. mGRPs: glial-restricted precursors; sPIF: synthetic PreImplantation Factor; Tac: Tacrolimus, CB: co-stimulatory blockade. *p < 0.05; **p < 0.01; ***p < 0.001. Data are presented as mean ± SD (one-way analysis of variance (ANOVA) followed by a post–hoc test (Bonferroni test).